These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30842705)

  • 1. Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer.
    Ganenko D; Dulskas A; Kuliešius Ž; Baltruškevičienė E; Urbonas V; Stratilatovas E
    Acta Med Litu; 2018; 25(3):161-165. PubMed ID: 30842705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
    Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
    Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada.
    Lima IS; Yasui Y; Scarfe A; Winget M
    Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
    Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
    JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.
    Gögenur M; Rosen AW; Iveson T; Kerr RS; Saunders MP; Cassidy J; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; Pearson S; Boyd KA; Briggs AH; Waterston A; Medley L; Ellis R; Dhadda AS; Harrison M; Falk S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Cunningham D; Hickish T; Gollins S; Wasan HS; Kelly C; Gögenur I; Holländer NH
    JAMA Surg; 2024 Aug; 159(8):865-871. PubMed ID: 38865139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
    de Gramont A; Van Cutsem E; Schmoll HJ; Tabernero J; Clarke S; Moore MJ; Cunningham D; Cartwright TH; Hecht JR; Rivera F; Im SA; Bodoky G; Salazar R; Maindrault-Goebel F; Shacham-Shmueli E; Bajetta E; Makrutzki M; Shang A; André T; Hoff PM
    Lancet Oncol; 2012 Dec; 13(12):1225-33. PubMed ID: 23168362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.
    Sun Z; Adam MA; Kim J; Nussbaum DP; Benrashid E; Mantyh CR; Migaly J
    Dis Colon Rectum; 2016 Feb; 59(2):87-93. PubMed ID: 26734965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
    Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN
    BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery.
    Salazar MC; Rosen JE; Wang Z; Arnold BN; Thomas DC; Herbst RS; Kim AW; Detterbeck FC; Blasberg JD; Boffa DJ
    JAMA Oncol; 2017 May; 3(5):610-619. PubMed ID: 28056112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 13. Timing of adjuvant chemotherapy in colorectal cancer.
    Dos Santos LV; Faria TM; Lima AB; Abdalla KC; de Moraes ED; Cruz MR; Lima JP
    Colorectal Dis; 2016 Sep; 18(9):871-6. PubMed ID: 26900665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
    Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
    Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy Is Associated with Improved Survival for Stage III Colon Cancer When Initiated Beyond 8 Weeks.
    Ahmed FA; Wu VS; Kakish H; Rothermel L; Stein SL; Steinhagen E; Hoehn R
    J Gastrointest Surg; 2023 Sep; 27(9):1913-1924. PubMed ID: 37340108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
    Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study.
    Kim YW; Choi EH; Kim BR; Ko WA; Do YM; Kim IY
    Oncotarget; 2017 Oct; 8(45):80061-80072. PubMed ID: 29108388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer.
    Jeong WK; Shin JW; Baek SK
    Ann Surg Treat Res; 2015 Sep; 89(3):124-30. PubMed ID: 26366381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time interval between surgery and adjuvant chemotherapy in patients with gastric cancer after gastrectomy: a population-based cohort study using a nationwide claim database.
    Maeng CH; Kim H; Kim M
    Ther Adv Med Oncol; 2024; 16():17588359241241972. PubMed ID: 38559613
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.